Clinical Trials Browser

OTHER × Unspecified Adult Solid Tumor, Protocol Specific × Trastuzumab × Clear all

NCT00084513 2010-02-12

Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific